Bone pain is one of the most common complications in cancer patients with bone metastases. Previous findings that inhibitors of osteoclastic bone resorption such as bisphosphonates (BPs) reduce bone pain suggest a critical role of osteoclasts. Osteoclasts destroy bone by secreting protons, thereby making adjacent microenvironment acidic. Because acidosis is a well-known cause of pain, it is plausible that an osteoclasts-created acidic microenvironment may cause bone pain associated with cancer colonization in bone. To test this notion, we studied an animal model in which inoculation of MRMT-1 rat breast cancer cells into the tibiae in female rats induced hyperalgesia. Radiographic and histological analyses demonstrated that MRMT-1 cells caused aggressive bone destruction with an increased number of osteoclasts. Behavioral analyses showed that rats exhibited hyperalgesia in the tumor-inoculated legs. The BP zoledronic acid (ZOL) significantly reduced the hyperalgesia. In addition, immunohistochemical examinations revealed that c-Fos expression in the ipsilateral spinal cord neurons was increased. ZOL decreased these c-Fos-positive neurons. To investigate the role of acidosis, mRNA expression of acid-sensing receptors including acid-sensing channels (ASICs) and transient receptor potential channel-vanilloid subfamily member 1 (TRPV1) in the dorsal root ganglions (DRGs) was determined. The expression of ASIC1a and ASIC1b was increased in the ipsilateral DRGs, whereas the ASIC3 and TRPV1 expression was not changed. Of note, ZOL reduced the expression of ASIC1a and ASIC1b. In conclusion, our data suggest that an acidic microenvironment created by osteoclasts, at least in part, contributes to the induction of hyperalgesia through upregulating ASICs expression.
bone pain bone metastasis bisphosphonates osteoclastic bone resorption acidosis
This is a preview of subscription content, log in to check access.
Nagae, M, Hiraga, T, Wakabayashi, H, Wang, L, Iwata, K, Yoneda, T 2006Osteoclasts play a part in pain due to the inflammation adjacent to boneBone3911071115PubMedCrossRefGoogle Scholar
Medhurst, SJ, Walker, K, Bowes, M, Kidd, BL, Glatt, M, Muller, M, Hattenberger, M, Vaxelaire, J, O’Reilly, T, Wotherspoon, G, Winter, J, Green, J, Urban, L 2002A rat model of bone cancer painPain96129140PubMedCrossRefGoogle Scholar
Hargreaves, K, Dubner, R, Brown, F, Flores, C, Joris, J 1988A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain327788PubMedCrossRefGoogle Scholar
Tagawa, K, Taya, C, Hayashi, Y, Nakagawa, M, Ono, Y, Fukuda, R, Karasuyama, H, Toyama-Sorimachi, N, Katsui, Y, Hata, S, Ishiura, S, Nonaka, I, Seyama, Y, Arahata, K, Yonekawa, H, Sorimachi, H, Suzuki, K 2000Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2AHum Mol Genet913931402PubMedCrossRefGoogle Scholar
Hiraga, T, Myoui, A, Choi, ME, Yoshikawa, H, Yoneda, T 2006Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-β enhances bone metastases in breast cancerCancer Res6620672073PubMedCrossRefGoogle Scholar
Iwata, K, Takahashi, O, Tsuboi, Y, Ochiai, H, Hibiya, J, Sasaki, T, Yamaguchi, Y, Sumino, R 1998Fos protein induction in the medullary dorsal horn and first segment of the spinal cord by tooth-pulp stimulation in catsPain752736PubMedCrossRefGoogle Scholar
Hunt, SP, Pini, A, Evan, G 1987Induction of Fos-like protein in spinal cord neurons following sensory stimulationNature (Lond)328632634CrossRefGoogle Scholar
Bullitt, E 1990Expression of c-fos-like protein as a marker for neural activity following noxious stimulation in the ratJ Comp Neurol296517530PubMedCrossRefGoogle Scholar
Mach, DB, Rogers, SD, Sabino, MC, Luger, NM, Schwei, MJ, Pomonis, JD, Keyser, CP, Clohisy, DR, Adams, DJ, O’Leary, P, Mantyh, PW 2002Origins of skeletal pain: sensory and sympathetic innervation of the mouse femurNeuroscience113155166PubMedCrossRefGoogle Scholar